In Vitro and In Vivo Neuroprotective Effects of Stellettin B Through Anti-Apoptosis and the Nrf2/HO-1 Pathway

Pharmaceutical agents for halting the progression of Parkinson’s disease (PD) are lacking. The current available medications only relieve clinical symptoms and may cause severe side effects. Therefore, there is an urgent need for novel drug candidates for PD. In this study, we demonstrated the neuro...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Mar Drugs
Main Authors: Feng, Chien-Wei, Chen, Nan-Fu, Wen, Zhi-Hong, Yang, Wen-Ya, Kuo, Hsiao-Mei, Sung, Ping-Jyun, Su, Jui-Hsin, Cheng, Shu-Yu, Chen, Wu-Fu
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2019
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6627894/
https://ncbi.nlm.nih.gov/pubmed/31146323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/md17060315
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki